ログイン 会員登録
icon_bulk_order一括注文 Acrobiosystems for English
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
phone
Your Position: ホーム > CD46

CD46

概要

Name:Membrane cofactor protein
Target Synonym:TLX,MCP,CD46,CD46 Molecule,Membrane Cofactor Protein (CD46, Trophoblast-Lymphocyte Cross-Reactive Antigen),Antigen Identified By Monoclonal Antibody TRA-2-10,CD46 Molecule, Complement Regulatory Protein,CD46 Antigen, Complement Regulatory Protein,Trophoblast Leukocyte Common Antigen,MIC10,Trophoblast-Lymphocyte Cross-Reactive Antigen,Complement Membrane Cofactor Protein,Trophoblast Leucocyte Common Antigen,Measles Virus Receptor,CD46 Antigen,TRA2.10,AHUS2,Membrane cofactor protein,MGC26544
Number of Launched Drugs:0
Number of Drugs in Clinical Trials:3
Lastest Research Phase:Phase 2 Clinical

製品リスト製品比較と製品注文

製品仕様別:
製品カテゴリー別:
種類別:
タグ別:
コンジュゲート:
製造番号 種類 製品説明 構造 純度 特徴
CD6-H5254 Human Human CD46 Protein, Fc Tag (MALS verified)
CD6-H5254-structure
CD6-H5254-sds
CD6-H5226 Human Human CD46 Protein, His Tag (MALS verified)
CD6-H5226-structure
CD6-H5226-sds
ACRO Quality

生物活性データの一部

CD6-H5226-ELISA
 CD46 ELISA

Immobilized Human CD46, His Tag (Cat. No. CD6-H5226) at 1 μg/mL (100 μL/well) can bind FG-3246 (FOR46), Human IgG1 kappa with a linear range of 0.3-2 ng/mL (QC tested).

CD6-H5254-MALS-HPLC
CD46 MALS images

The purity of Human CD46 Protein, Fc Tag (Cat. No. CD6-H5254) is more than 90% and the molecular weight of this protein is around 85-105 kDa verified by SEC-MALS.

Synonym Name

CD46,AHUS2,MCP,MIC10,TLX,TRA2.10

Background

Complement regulatory protein CD46 is also known as membrane Cofactor Protein (MCP), is a type I membrane protein and is a regulatory part of the complement system. CD46 is expressed by all cells except erythrocytes. MCP acts as a cofactor for complement factor I, a serine protease which protects autologous cells against complement-mediated injury by cleaving C3b and C4b deposited on host tissue, and also acts as a costimulatory factor for T-cells which induces the differentiation of CD4+ into T-regulatory 1 cells. In T-cells by binding to CD46, A number of viral and bacterial pathogens seem to exploit this property and directly induce an immunosuppressive phenotype. Defects in CD46 are a cause of susceptibility to hemolytic uremic syndrome atypical type 2 (AHUS2).

Clinical and Translational Updates

臨床試験情報

Name Research Code Research Phase Company Indications Clinical Trials
FOR-46 FOR-46; FG-3246 Phase 2 Clinical University Of California San Diego, Fortis Therapeutics Inc Prostatic Neoplasms, Castration-Resistant; Multiple Myeloma; Prostatic Neoplasms Details
Enadenotucirev ColoAd-1; Oncolytic Ad11/Ad3 Phase 1 Clinical Akamis Bio Ltd Ovarian Neoplasms; Rectal Neoplasms; Squamous Cell Carcinoma of Head and Neck; Colonic Neoplasms; Neoplasms, Glandular and Epithelial; Urinary Bladder Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung Details
YS-5 YS-5 Phase 1 Clinical Fortis Therapeutics Inc, United States Department Of Defense Prostatic Neoplasms, Castration-Resistant; Prostatic Neoplasms Details
FOR-46 FOR-46; FG-3246 Phase 2 Clinical University Of California San Diego, Fortis Therapeutics Inc Prostatic Neoplasms, Castration-Resistant; Multiple Myeloma; Prostatic Neoplasms Details
Enadenotucirev ColoAd-1; Oncolytic Ad11/Ad3 Phase 1 Clinical Akamis Bio Ltd Ovarian Neoplasms; Rectal Neoplasms; Squamous Cell Carcinoma of Head and Neck; Colonic Neoplasms; Neoplasms, Glandular and Epithelial; Urinary Bladder Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung Details
YS-5 YS-5 Phase 1 Clinical Fortis Therapeutics Inc, United States Department Of Defense Prostatic Neoplasms, Castration-Resistant; Prostatic Neoplasms Details

This web search service is supported by Google Inc.

totopphone